Interactions between cyclosporine and newer antidepressant medications

American Journal of Kidney Diseases

Volumn 31, Issue 2, 1998, Pages 320-323

  Vella, John P ^a   Sayegh, Mohamed H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adverse drug reactions; Antidepressant; Cyclosporine; Cytochrome P450; Fluvoxamine; Nefazodone

Indexed keywords

ALLOPURINOL; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATENOLOL; BUMETANIDE; CALCITRIOL; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; FAMOTIDINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; FUROSEMIDE; LEVOTHYROXINE; NEFAZODONE; OMEPRAZOLE; PAROXETINE; PREDNISONE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DEPRESSION; DRUG BLOOD LEVEL; DRUG POTENTIATION; FEMALE; GLOMERULONEPHRITIS; HEADACHE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; TREMOR;

EID: 0031931260     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9469504     Document Type: Article

References (15)

1. McCabe MS, Corry RJ: Psychiatric illness and human renal transplantation. J Clin Psychiatry 39:293-400, 1978
2. Kiley DJ, Lam CS, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation 55:51-56, 1993
3. Devins GM, Mann J, Mandin H, Paul LC, Hons RB, Burgess ED, Taub K, Schorr S, Letourneau PK, Buckle S. Psychosocial predictors of survival in end-stage renal disease. J Nerv Ment Dis 178:127-133, 1990
4. Hilbrands LB, Hoitsma AJ, Koene RA: The effect of immunosuppressive drugs on quality of life after renal transplantation. Transplantation 59:1263-1270, 1995
5. Andrews JM, Nemeroff CB: Contemporary management of depression. Am J Med 97(6A):24S-32S, 1994
6. Stoudemire A: New antidepressant drugs and the treatment of depression in the medically ill patient. Psychiatr Clin North Am 19:495-514, 1996
7. Nemeroff CB, DeVane CL, Pollock BG: Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 153:311-320, 1996
8. Helms-Smith KM, Curtis SL, Hatton RC: Apparent interaction between nefazodone and cyclosporine. Ann Intern Med 125:424, 1996
9. Riesenman C: Antidepressant drug interactions and the cytochrome P450 system: A critical appraisal. Pharmacotherapy 15:84S-99S
10. Turgeon DK, Leichtman AB, Lown KS, et al: P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients. Clin Pharmacol Ther 56:253-260, 1994
11. Harvey AT, Preskorn SH: Cytochrome P450 enzymes: Interpretation of their interactions with selective serotonin reuptake inhibitors. Part II. J Clin Psychopharmacol 16:345-355, 1996
12. Vella JP, Sayegh MH: Current and emerging immunosuppressant strategies in renal transplantation. Postgrad Med J 3:386-390, 1997
13. Lake KD: Management of drug interactions with cyclosporine. Pharmacotherapy 11:1108-1188, 1991
14. DeVane CL: Pharmacokinetics of the newer antidepressants: Clinical relevance. Am J Med 97:13S-23S, 1994
15. Matas AJ, Gillingham KJ, Payne WD, et al: The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 57:857-859, 1994